التفاصيل البيبلوغرافية
| العنوان: |
Cytotoxicity and molecular docking analysis of racemolactone I, a new sesquiterpene lactone isolated from Inula racemosa. |
| المؤلفون: |
Alam, Perwez, Tyagi, Rama, Farah, Mohammad Abul, Rehman, Md. Tabish, Hussain, Afzal, AlAjmi, Mohamed Fahad, Siddiqui, Nasir Ali, Al-Anazi, Khalid Mashay, Amin, Saima, Mujeeb, Mohd., Mir, Showkat R. |
| المصدر: |
Pharmaceutical Biology; Dec2021, Vol. 59 Issue 1, p941-952, 12p |
| مصطلحات موضوعية: |
MOLECULAR docking, MITOCHONDRIAL membranes, MEMBRANE potential, HELA cells, LACTATE dehydrogenase |
| People: |
POLO, Marco, 1254-ca. 1323 |
| مستخلص: |
Traditionally, Inula racemosa Hook. f. (Asteraceae) has been reported to be effective in cancer treatment which motivated the authors to explore the plant for novel anticancer compounds. To isolate and characterize new cytotoxic phytoconstituents from I. racemosa roots. The column chromatography of I. racemosa ethyl acetate extract furnished a novel sesquiterpene lactone whose structure was established by NMR (1D/2D), ES-MS and its cytotoxic properties were assessed on HeLa, MDAMB-231, and A549 cell lines using MTT and LDH (lactate dehydrogenase) assays. Further, morphological changes were analyzed by flow cytometry, mitochondrial membrane potential, AO-EtBr dual staining, and comet assay. Molecular docking and simulation were performed using Glide and Desmond softwares, respectively, to validate the mechanism of action. The isolated compound was identified as racemolactone I (compound 1). Amongst the cell lines tested, considerable changes were observed in HeLa cells. Compound 1 (IC50 = 0.9 µg/mL) significantly decreased cell viability (82%) concomitantly with high LDH release (76%) at 15 µg/mL. Diverse morphological alterations along with significant increase (9.23%) in apoptotic cells and decrease in viable cells were observed. AO-EtBr dual staining also confirmed the presence of 20% apoptotic cells. A gradual decrease in mitochondrial membrane potential was observed. HeLa cells showed significantly increased comet tail length (48.4 µm), indicating broken DNA strands. In silico studies exhibited that compound 1 binds to the active site of Polo-like kinase-1 and forms a stable complex. Racemolactone I was identified as potential anticancer agent, which can further be confirmed by in vivo investigations. [ABSTRACT FROM AUTHOR] |
|
Copyright of Pharmaceutical Biology is the property of Taylor & Francis Ltd and its content may not be copied or emailed to multiple sites or posted to a listserv without the copyright holder's express written permission. However, users may print, download, or email articles for individual use. This abstract may be abridged. No warranty is given about the accuracy of the copy. Users should refer to the original published version of the material for the full abstract. (Copyright applies to all Abstracts.) |
| قاعدة البيانات: |
Complementary Index |
Full Text Finder